1. Scrip
  2. >>Business
  3. >>Financing

Parallel Trade Adds Up As Abacus Prepares IPO

 
• By Kevin Grogan

With revenues from its parallel trade business climbing 50% year-on-year since 2015, Denmark's Abacus is to seek a listing in Germany to help it keep up with demand.

Abacus
Abacus counting on an IPO • Source: Shutterstock

Business is booming at Danish parallel trade company Abacus Medicine which has unveiled plans to list on the Frankfurt Stock Exchange.

The initial public offering is expected to be completed by the end of 2018. It will consist of newly issued...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Financing

More from Business

Novartis’s Cosentyx Suffers Rare Phase III Fail

 
• By Kevin Grogan

Multi-blockbuster falls short in a giant cell arteritis study.

In Brief: BioVersys And Shionogi Align In Non-Tuberculous Mycobacteria R&D

 
• By Joseph Haas

Deal Snapshot: Having recently raised an $89m IPO, BioVersys is partnering on and optioning rights to a preclinical NTM development program with Shionogi.

BerGenBio Plumps For Oncoinvent From Long List Of 50 Suitors

 
• By Kevin Grogan

The merger with a fellow Norwegian biotech comes a few months after its lead asset, bemcentinib, bit the dust.